Precision Biosciences (DTIL) Current Deferred Revenue (2018 - 2025)
Precision Biosciences (DTIL) posted Current Deferred Revenue of $6.25 million for fiscal Q3 2025 (quarter ended Sep 30, 2025), compared with $175,000 a year earlier and up 4.3% from the prior quarter.
Powered by 
Analysis
Precision Biosciences (DTIL) Current Deferred Revenue (2018 - 2025) Analysis & Trends
At the end of FY2024 (ended Dec 31, 2024), Precision Biosciences' Current Deferred Revenue came in at $2.96 million, down 75.4% from FY2023.
- Annual Current Deferred Revenue shows a five-year compound annual growth rate of -29.1% (FY2019 to FY2024).
- In prior fiscal years, Precision Biosciences' Current Deferred Revenue was $12.04 million in FY2023 (-73.9%), $46.19 million in FY2022 (+117.4%), $21.24 million in FY2021 (-29.7%) and $30.24 million in FY2020 (+83.4%).
- The fiscal Q3 2025 figure stands as the highest quarterly Current Deferred Revenue since fiscal Q4 2023.
- On a year-over-year basis, Current Deferred Revenue increased in 1 of the last six quarters, with an average decline of 50.3%.
- The strongest year-over-year quarter for Current Deferred Revenue in the past five years was fiscal Q1 2021, with growth of 299.0%; the weakest was fiscal Q3 2024, with a decline of 99.0%.
- According to Business Quant data, Current Deferred Revenue for the three prior fiscal quarters was $5.99 million (Q2 2025), $5.73 million (Q1 2025) and $2.96 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Precision Biosciences | 165.47 Mn | -183.71 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 6.25 Mn |
| Jun 30, 2025 | 5.99 Mn |
| Mar 31, 2025 | 5.73 Mn |
| Dec 31, 2024 | 2.96 Mn |
| Sep 30, 2024 | 175,000.00 |
| Jun 30, 2024 | 526,000.00 |
| Mar 31, 2024 | 2.41 Mn |
| Dec 31, 2023 | 12.04 Mn |
| Sep 30, 2023 | 17.45 Mn |
| Jun 30, 2023 | 23.81 Mn |
| Mar 31, 2023 | 38.27 Mn |
| Dec 31, 2022 | 46.19 Mn |
| Sep 30, 2022 | 48.41 Mn |
| Jun 30, 2022 | 41.51 Mn |
| Mar 31, 2022 | 19.69 Mn |
| Dec 31, 2021 | 21.24 Mn |
| Sep 30, 2021 | 21.98 Mn |
| Jun 30, 2021 | 22.22 Mn |
| Mar 31, 2021 | 53.09 Mn |
| Dec 31, 2020 | 30.24 Mn |
API Access
Precision Biosciences Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=DTIL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "DTIL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=DTIL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();